RSS Feeds
Lithium Toxicity Associated with a Trichobezoar
- Denyse Thornley-Brown, MD;
- John H. Galla, MD;
- Phillip D. Williams, MD;
- K. Sashi Kant, MD; and
- Mitchell Rashkin, MD
Excerpt
We present an unusual case of lithium toxicity characterized by recurrently elevated serum lithium levels despite adequate hemodialysis.
Case Report A 47-year-old woman presented in an unresponsive state to the emergency department of the University of Cincinnati Hospital. She had a history of a bipolar disorder, keratosis follicularis, and a seizure disorder. Medications included tranylcypromine sulfate, 45 mg daily; benztropine mesylate, 1 mg daily; carbamazepine, 200 mg thrice daily; perphenazine, 16 mg thrice daily; lorazepam; and vitamin A. Lithium carbonate (Litho-bid, CIBA Pharmaceutical, Edison, New Jersey) had been discontinued 1 year before presentation because of an adverse skin reaction. On
This 100-word excerpt has been provided in the absence of an abstract.
Article and Author Information
-
From the University of Cincinnati Medical Center, Cincinnati, Ohio. For current author addresses, see end of text.
-
Requests for Reprints: Denyse Thornley-Brown, MD, Department of Internal Medicine, Division of Nephrology and Hypertension, University of Cincinnati Medical Center, 231 Bethesda Avenue, Cincinnati, OH 45267-0585.
-
Current Author Addresses: Drs. Thornley-Brown, Galla, and Kant: Department of Internal Medicine, Division of Nephrology and Hypertension, University of Cincinnati Medical Center, 231 Bethesda Avenue, Cincinnati, OH 45267-0585.
Dr. Williams: Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati Medical Center, 231 Bethesda Avenue, Cincinnati, OH 45267-0585.
Dr. Rashkin: Department of Internal Medicine, Division of Pulmonary Diseases, University of Cincinnati Medical Center, 231 Bethesda Avenue, Cincinnati, OH 45267-0585.
